Publications 2023 2022 2021 2020 2018-2019 2016-2017 2014-2015 2012-2013 2010-2011 2024 Safety and Effectiveness of Glucagon-like Peptide-1 Receptor Agonists in Inflammatory Bowel DiseaseDecember 24, 2024 Improving Differentiation of Crohn's Disease and Ulcerative Colitis Proteomes through Protein-Wide Association Study Feature Selection in Machine LearningNovember 28, 2024 Single-Cell and Spatial Multi-omics Reveal Interferon Signaling in the Pathogenesis of Perianal Fistulizing Crohn's DiseaseNovember 22, 2024 Consensus definition of a radiologically healed fistula on magnetic resonance imaging in perianal Crohn's disease: an international Delphi studyNovember 18, 2024 Noninvasive Stool RNA Test Approximates Disease Activity in Patients With Crohn's DiseaseNovember 12, 2024 Mucosal Single-Cell Profiling of Crohn's-Like Disease of the Pouch Reveals Unique Pathogenesis and Therapeutic TargetsJuly 31, 2024 Risankizumab Is Effective for The Management of Crohn's Disease of the PouchJuly 22, 2024 Quantification of Visceral Fat at the L5 Vertebral Body Level in Patients with Crohn's Disease Using T2-Weighted MRIJune 27, 2024 Lemann Index for assessing bowel damage in Crohn's disease: a real world studyJune 27, 2024 Perianal Fistulizing Crohn's Disease-Associated Anorectal and Fistula Cancers: Systematic Review and Expert ConsensusJune 13, 2024 First-in-Human Assessment of Gut Permeability in Crohn's Disease Patients Using Fluorophore TechnologyMay 30, 2024 Surgery for Crohn's Disease Is Associated With a Dysbiotic Microbiome and Metabolome: Results From Two Prospective CohortsMay 16, 2024 Correction to: Correlation Between Plasma and Fecal Biomarkers and Patient‑Reported Outcomes in Patients with Crohn's Disease and Ulcerative ColitisMay 16, 2024 Evaluating the Change in <sup>18</sup>F-Fluorodeoxyglucose Uptake in Perianal Fistulas on PET/CT over Time: A Serial Retrospective AnalysisMay 11, 2024 Strategies for Enhancing Inflammatory Bowel Disease Care in Pakistan: Bridging Gaps and Building CapacitiesMay 9, 2024 The IRE1α/XBP1 pathway sustains cytokine responses of group 3 innate lymphoid cells in inflammatory bowel diseaseMay 9, 2024 TOpCLASS Expert Consensus Classification of Perianal Fistulising Crohn's Disease: A Real-world Application in a Serial Fistula MRI CohortApril 20, 2024 Correlation Between Serum and Fecal Biomarkers and Patient-Reported Outcomes in Patients with Crohn's Disease and Ulcerative ColitisApril 5, 2024 Inflammatory and Malignant Uptake Along Crohn Perianal Fistula on 18 F-FDGMarch 27, 2024 Reply to: Beyond Discrimination: A Call for Comprehensive Assessment of Clinical Prediction Models in Inflammatory Bowel DiseaseMarch 8, 2024 View all 2024 Publications Back to top 2023 Artificial intelligence for discrimination of Crohn's disease and gastrointestinal tuberculosis: A systematic reviewDecember 7, 2023 Cardiovascular Safety of Ozanimod in Patients With Ulcerative Colitis: True North and Open-Label Extension AnalysesDecember 1, 2023 Changes in Therapy Are Not Associated With Increased Remission in Patients With Crohn's Disease of the PouchNovember 17, 2023 ReplyNovember 12, 2023 Three-Dimensional Modeling to Guide Interventional Endoscopy in Fibrostenotic Crohn's DiseaseOctober 13, 2023 Risk of Major Adverse Cardiovascular Events in Immune-Mediated Inflammatory Disorders on Biologics and Small Molecules: Network Meta-AnalysisOctober 11, 2023 Long-Standing Symptomatic Fistulizing Perianal Crohn's Disease: Progression Beyond InflammationSeptember 14, 2023 Perineal hernia as a sequela of anal reconstruction surgeries in perianal Crohn's diseaseSeptember 11, 2023 Comparative Effectiveness of Biologic Therapies in Preventing Penetrating Complications in Patients With Crohn's DiseaseSeptember 6, 2023 Dietary Patterns Are Not Associated With Disease Activity Among Patients With Inflammatory Conditions of the Pouch in a Prospective CohortJuly 31, 2023 Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation StudyJuly 27, 2023 Health Disparities in Inflammatory Bowel Disease Care Driven by Rural Versus Urban Residence: Challenges and Potential SolutionsJune 23, 2023 Health Disparities in Inflammatory Bowel Disease Care Driven by Rural Versus Urban Residence: Challenges and Potential SolutionsJune 22, 2023 Yield of Serial Testing for Tuberculosis Exposure in Patients With Inflammatory Bowel Diseases: One Test is Not EnoughJune 18, 2023 Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve RemissionMay 19, 2023 Utilization of Treat-to-Target Monitoring Colonoscopy After Treatment Initiation in the US-Based Study of a Prospective Adult Research Cohort With Inflammatory Bowel DiseaseApril 13, 2023 Corticosteroids Increase the Risk of Invasive Fungal Infections More Than Tumor Necrosis Factor-Alpha Inhibitors in Patients With Inflammatory Bowel DiseaseMarch 13, 2023 Nonalcoholic Fatty Liver Disease Is a Risk Factor for Thiopurine Hepatotoxicity in Crohn's DiseaseFebruary 27, 2023 Pathogenesis of Perianal Fistulising Crohn's Disease: Current Knowledge, Gaps in Understanding, and Future Research DirectionsJanuary 19, 2023 A simple point-of-care assay accurately detects anti-spike antibodies after SARS-CoV-2 vaccinationJanuary 16, 2023 View all 2023 Publications Back to top 2022 ReplyNovember 15, 2022 Identifying Care Challenges as Opportunities for Research and Education in Inflammatory Bowel Disease in South AsiaOctober 28, 2022 Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or UstekinumabOctober 24, 2022 Identifying Care Challenges as Opportunities for Research and Education in Inflammatory Bowel Disease in South AsiaOctober 23, 2022 Treatment Patterns and Standardized Outcome Assessments Among Patients With Inflammatory Conditions of the Pouch in a Prospective Multicenter RegistrySeptember 9, 2022 Inflammatory Bowel Disease Is Associated With an Increased Risk of Incident Acute Arterial Events: Analysis of the United Kingdom BiobankSeptember 8, 2022 A Summary of the BRIDGe Summit on Damage-Related Progression of Ulcerative Colitis: Establishing Research PrioritiesAugust 14, 2022 Management of refractory inflammatory bowel diseaseJune 28, 2022 Tools for the Diagnosis and Management of Crohn's DiseaseMay 20, 2022 Development of the Endoscopic Pouch Score for Assessment of Inflammatory Conditions of the PouchMay 14, 2022 Reframing self-expandable metal stents for Crohn's stricturesMay 13, 2022 Recommendations on the Appropriate Management of Steroids and Discharge Planning During and After Hospital Admission for Moderate-Severe Ulcerative Colitis: Results of a RAND Appropriateness PanelApril 13, 2022 Therapeutic Drug Monitoring in Perianal Fistulizing Crohn's DiseaseApril 12, 2022 Reactogenicity of the Messenger RNA SARS-CoV-2 Vaccines Associated With Immunogenicity in Patients With Autoimmune and Inflammatory DiseaseApril 12, 2022 Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel DiseaseMarch 21, 2022 Predicting Risk of Surgery in Patients With Small Bowel Crohn's Disease Strictures Using Computed Tomography and Magnetic Resonance EnterographyJanuary 15, 2022 Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: Systematic review and meta-analysisSeptember 2, 2021 The Development and Initial Findings of A Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD)August 26, 2021 Back to top 2021 A New Way to Assess the Trajectory of Remission in Crohn Disease: Correlating Drug Levels With a Noninvasive Blood Biomarker of Mucosal RemissionFebruary 13, 2023 Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitorsNovember 23, 2021 Addressing unmet needs from a new frontier of IBD: the South Asian IBD AllianceOctober 9, 2021 Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: Systematic review and meta-analysisSeptember 2, 2021 Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2 : A Prospective Cohort StudyAugust 30, 2021 Effectiveness and Safety of Combining Tofacitinib With a Biologic in Patients With Refractory Inflammatory Bowel DiseasesMay 26, 2021 Rational Combination Therapy to Overcome the Plateau of Drug Efficacy in Inflammatory Bowel DiseaseMay 7, 2021 Multidisciplinary management of perianal Crohn's diseaseApril 26, 2021 Glucocorticoids and B Cell Depleting Agents Substantially Impair Immunogenicity of mRNA Vaccines to SARS-CoV-2April 14, 2021 Editorial: use of intestinal ultrasound in the scoring of Crohn's disease activity in clinical trials-is it ready for prime time yet?March 21, 2021 Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Disease Outcome and Response to TherapyMarch 17, 2021 <em>Debaryomyces</em> is enriched in Crohn's disease intestinal tissue and impairs healing in miceMarch 12, 2021 Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodiesMarch 5, 2021 SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodiesFebruary 17, 2021 MRE Evaluation of Intestinal Inflammation: Qualitative and Quantitative AssessmentFebruary 2, 2021 Medical and Endoscopic Management of Crohn DiseaseFebruary 2, 2021 Inflammatory Bowel Disease, Celiac Disease, and Primary Sclerosing Cholangitis: Is There a Link?January 1, 2021 Evaluation of Nonalcoholic Fatty Liver Disease in Pediatric Patients With Inflammatory Bowel DiseaseDecember 21, 2020 Association Between Vedolizumab Levels, Anti-vedolizumab Antibodies, and Endoscopic Healing Index in a Large Population of Patients with Inflammatory Bowel DiseasesOctober 22, 2020 Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC ConsortiumOctober 17, 2020 View all 2021 Publications Back to top 2020 Reversing the Tide: Improving the Recruitment of Patients With Inflammatory Bowel Disease in Clinical Trials in the United StatesFebruary 13, 2023 Inflammatory Bowel Disease, Celiac Disease, and Primary Sclerosing Cholangitis: Is There a Link?January 1, 2021 Editorial: crystal gazing with magnetic resonance enterography to predict the response to TNF-alpha inhibitors in Crohn's diseaseDecember 2, 2020 Association Between Vedolizumab Levels, Anti-vedolizumab Antibodies, and Endoscopic Healing Index in a Large Population of Patients with Inflammatory Bowel DiseasesOctober 22, 2020 Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC ConsortiumOctober 17, 2020 Pouchitis: Bile Acid Deficiency Links Inflammation to DysbiosisAugust 18, 2020 Disease and Treatment Patterns Among Patients With Pouch-related Conditions in a Cohort of Large Tertiary Care Inflammatory Bowel Disease Centers in the United StatesAugust 4, 2020 Postprandial Chylomicron Output and Transport Through Intestinal Lymphatics Are Not Impaired in Active Crohn's DiseaseJuly 19, 2020 Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative ColitisJuly 7, 2020 Editorial: transperineal ultrasound in addition to a transabdominal ultrasound in ulcerative colitis-one more arrow in the quiver of non-invasive diagnosticsJune 28, 2020 Reply to the Letter to the Editor: Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn's DiseaseMarch 5, 2020 Imaging Findings of Ileal Inflammation at Computed Tomography and Magnetic Resonance Enterography: What do They Mean When Ileoscopy and Biopsy are Negative?January 22, 2020 Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn's DiseaseJanuary 8, 2020 Impact of Bariatric Surgery on the Long-term Disease Course of Inflammatory Bowel DiseaseOctober 16, 2019 Back to top 2018-2019 Multiphase Computed Tomographic Enterography: Diagnostic Yield and Efficacy in Patients With Suspected Small Bowel BleedingJanuary 30, 2020 Volvulus of the ileal pouch-anal anastomosis: a meta-narrative systematic review of frequency, diagnosis, and treatment outcomesDecember 21, 2019 Magnetic resonance enterography features of small bowel Crohn's disease activity: an inter-rater reliability study of small bowel active inflammation in clinical practice settingMay 30, 2019 The Role of the Radiologist in Determining Disease Severity in Inflammatory Bowel DiseasesMay 13, 2019 Beyond the Label: Ensuring That Drug Benefits Outweigh Risks in the Food and Drug Administration's Risk Evaluation and Mitigation Strategy ProgramApril 30, 2019 Crohn's Disease Is Associated With an Increased Prevalence of Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study Using Magnetic Resonance Proton Density Fat Fraction MappingMarch 17, 2019 Efficacy of Vedolizumab for Refractory Pouchitis of the Ileo-anal Pouch: Results From a Multicenter US CohortFebruary 28, 2019 Successful Treatment of Pyoderma Gangrenosum with Concomitant Tofacitinib and InfliximabFebruary 13, 2019 Mucinous Small Bowel Adenocarcinoma Mimicking Change to Internal Penetrating Phenotype in Well-controlled Crohn's DiseaseOctober 19, 2018 Ustekinumab Is Effective for the Treatment of Crohn's Disease of the Pouch in a Multicenter CohortOctober 9, 2018 Anti-Tumour Necrosis Factor Therapy for Inflammatory Bowel Diseases Do Not Impact Serious Infections after ArthroplastySeptember 27, 2018 Novel Imaging Approaches in Inflammatory Bowel DiseasesJuly 17, 2018 Diffusion-weighted MRI in inflammatory bowel diseaseMay 10, 2018 Phenotype and Clinical Course of Inflammatory Bowel Disease With Co-existent Celiac DiseaseMay 10, 2018 Predictors of Durability of Radiological Response in Patients With Small Bowel Crohn's DiseaseApril 19, 2018 De-novo Inflammatory Bowel Disease After Bariatric Surgery: A Large Case SeriesDecember 23, 2017 Bariatric Surgery Is Acceptably Safe in Obese Inflammatory Bowel Disease Patients: Analysis of the Nationwide Inpatient SampleOctober 12, 2017 Back to top 2016-2017 Isolated Acute Terminal Ileitis Without Preexisting Inflammatory Bowel Disease Rarely Progresses to Crohn's DiseaseOctober 25, 2017 Ustekinumab and Anti-Interleukin-23 Agents in Crohn's DiseaseAugust 26, 2017 Transmural Healing and MRI Remission: New Promising Therapeutic Targets in Crohn's DiseaseAugust 9, 2017 Crohn's disease diagnosis, treatment approach, and management paradigm: what the radiologist needs to knowFebruary 18, 2017 Ustekinumab in treatment of Crohn's disease: design, development, and potential place in therapyDecember 14, 2016 Computed Tomography and Magnetic Resonance Enterography in Crohn's Disease: Assessment of Radiologic Criteria and Endpoints for Clinical Practice and TrialsAugust 11, 2016 Update on Magnetic Resonance Imaging and Ultrasound Evaluation of Crohn's DiseaseMay 28, 2016 Radiological Response Is Associated With Better Long-Term Outcomes and Is a Potential Treatment Target in Patients With Small Bowel Crohn's DiseaseMay 12, 2016 Incremental diagnostic yield of chromoendoscopy and outcomes in inflammatory bowel disease patients with a history of colorectal dysplasia on white-light endoscopySeptember 27, 2015 Back to top 2014-2015 Incremental diagnostic yield of chromoendoscopy and outcomes in inflammatory bowel disease patients with a history of colorectal dysplasia on white-light endoscopySeptember 27, 2015 Update on the Medical Management of Crohn's DiseaseSeptember 14, 2015 Melanoma and non-melanoma skin cancer in inflammatory bowel disease patients following tumor necrosis factor-α inhibitor monotherapy and in combination with thiopurines: analysis of the Food and Drug Administration Adverse Event Reporting SystemOctober 1, 2014 Assessing the likelihood of new-onset inflammatory bowel disease following tumor necrosis factor-alpha inhibitor therapy for rheumatoid arthritis and juvenile rheumatoid arthritisSeptember 18, 2014 Risk of Myeloid Neoplasms in Inflammatory Bowel Disease Patients Is Linked to Exposure to Thiopurines and Not With Tumor Necrosis Factor-alpha InhibitorsAugust 28, 2014 Effect of tumor necrosis factor-α inhibitors on drug-induced pancreatitis in inflammatory bowel diseaseJuly 2, 2014 Radiographical evaluation of ulcerative colitisMay 21, 2014 Back to top 2012-2013 Infectious complications of TNF-α inhibitor monotherapy versus combination therapy with immunomodulators in inflammatory bowel disease: analysis of the Food and Drug Administration Adverse Event Reporting SystemOctober 1, 2013 Hospitalizations for vaccine preventable pneumonias in patients with inflammatory bowel disease: a 6-year analysis of the Nationwide Inpatient SampleJuly 3, 2013 The metoclopramide black box warning for tardive dyskinesia: effect on clinical practice, adverse event reporting, and prescription drug lawsuitsJune 6, 2013 Alleged isotretinoin-associated inflammatory bowel disease: disproportionate reporting by attorneys to the Food and Drug Administration Adverse Event Reporting SystemMay 21, 2013 Ischaemic colitis in rheumatoid arthritis patients receiving tumour necrosis factor-α inhibitors: an analysis of reports to the US FDA Adverse Event Reporting SystemApril 13, 2013 Ischemic colitis with type I interferons used in the treatment of hepatitis C and multiple sclerosis: an evaluation from the food and drug administration adverse event reporting system and review of the literatureMarch 29, 2013 Lubiprostone induced ischemic colitisJanuary 25, 2013 Relationship between mesenteric abnormalities on computed tomography and malignancy: clinical findings and outcomes of 359 patientsNovember 29, 2012 Concomitant antibiotic usage does not augment the risk of inflammatory bowel disease with isotretinoin treatment for acne: a review of the Food and Drug Administration Adverse Event Reporting SystemOctober 12, 2012 T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH studyOctober 4, 2012 Use of polyethylene glycol-based colonoscopy preparations before rectal argon plasma coagulation: lessons still to be learned by practicing gastroenterologistsJune 29, 2012 Simulated comparison of topical and oral formulations of 5-aminosalicylate for the treatment of ulcerative colitisMay 31, 2012 Do gastroenterologists adhere to diagnostic and treatment guidelines for celiac disease?October 1, 2011 Back to top 2010-2011 Ischemic colitis masquerading as colonic tumor: case report with review of literatureJanuary 6, 2012 Method for the current reviewSeptember 28, 2011 DiarrheaSeptember 28, 2011 ConstipationSeptember 28, 2011 Other effects on the colonSeptember 28, 2011 Hepatosplenic T-cell lymphoma in patients receiving TNF-α inhibitor therapy: expanding the groups at riskSeptember 24, 2011 Lower body weight and female gender: hyperphosphatemia risk factors after sodium phosphate preparationsJune 17, 2011 Esophageal small cell carcinoma with synchronous renal cell carcinoma: a case report with review of the literatureMay 10, 2011 Calcium phosphate nephropathy from colonoscopy preparations: effect of body weightMarch 6, 2010 A dynamic model of once-daily 5-aminosalicylic acid predicts clinical efficacyDecember 30, 2009 Back to top